The DOI matches its Crossref record; 13 of the 13 references it cites were found in a registry or an index.
Clinical correlations and prognosis based on serum autoantibodies in patients with systemic sclerosis
Abstract
Of 397 systemic sclerosis (scleroderma) patients from the University of Pittsburgh, who had serum determinations of both anti–Scl‐70 and anticentromere antibody (ACA), 26% had anti‐Scl‐70 and 22% had ACA. No patient had both autoantibodies. Weak associations with HLA–DR5 and HLA‐DR1 were detected with anti‐Scl‐70 and ACA, respectively. ACA was found almost exclusively (96%) in patients with limited cutaneous scleroderma (the CREST syndrome variant), but the majority (57%) of patients with limited scleroderma did not have this antibody. Among patients with limited scleroderma, those with ACA more often had calcinosis and telangiectasias and less often had pulmonary interstitial fibrosis and restrictive lung disease. However, the frequency of pulmonary hypertension and the survival rates were similar in the ACA + and ACA‐ limited scleroderma patients. Two‐thirds of patients with anti‐Scl‐70 had diffuse scleroderma, but only 33% of all diffuse scleroderma patients had this antibody. Within the subset of diffuse scleroderma, anti‐Scl‐70 was associated with peripheral vascular disease (digital pitting scars) and pulmonary interstitial fibrosis, but was not predictive of cardiac or renal involvement or survival. ACA and anti–Scl‐70 are useful in diagnosing and classifying systemic sclerosis variants and in predicting the natural course of the disease. Their mutually exclusive occurrence suggests either 2 separate clinical entities or important host factors determining their production.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Preliminary criteria for the classification of systemic sclerosis (scleroderma)
Masi, A. T., & Subcommittee For Scleroderma Criteria of the American Rheumatism Association Diagnostic and Therapeutic Criteria Committee (1980) · Arthritis & Rheumatism · doi:10.1002/art.1780230510 · Cited by 4,898
Association of the B-Cell Alloantigen DRw4 with Rheumatoid Arthritis
Stastny, P. (1978) · New England Journal of Medicine · doi:10.1056/nejm197804202981602 · Cited by 1,163
Autoantibody to centromere (kinetochore) in scleroderma sera.
Moroi, Y., Peebles, C., Fritzler, M. J., Steigerwald, J., & Tan, E. M. (1980) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.77.3.1627 · Cited by 729
Diversity of antinuclear antibodies in progressive systemic sclerosis
Tan, E. M., Rodnan, G. P., Garcia, I., Moroi, Y., Fritzler, M. J., & Peebles, C. (1980) · Arthritis & Rheumatism · doi:10.1002/art.1780230602 · Cited by 524
VAN ROOD, J. J., VAN LEEUWEN, A., & PLOEM, J. S. (1976) · Nature · doi:10.1038/262795a0 · Cited by 483
The CREST syndrome: A distinct serologic entity with anticentromere antibodies
Fritzler, M. J., Kinsella, T. D., & Garbutt, E. (1980) · The American Journal of Medicine · doi:10.1016/0002-9343(80)90462-3 · Cited by 366
D-Penicillamine Therapy in Progressive Systemic Sclerosis (Scleroderma): A Retrospective Analysis
STEEN, V. D., MEDSGER, T. A., & RODNAN, G. P. (1982) · Annals of Internal Medicine · doi:10.7326/0003-4819-97-5-652 · Cited by 322
Self-citationSteen, V. D., Ziegler, G. L., Rodnan, G. P., & Medsger, T. A. (1984) · Arthritis & Rheumatism · doi:10.1002/art.1780270202 · Cited by 225
Self-citationEarnshaw, W., Bordwell, B., Marino, C., & Rothfield, N. (1986) · Journal of Clinical Investigation · doi:10.1172/jci112320 · Cited by 210
Serum antinuclear antibodies in progressive systemic sclerosis (scleroderma)
Rothfield, N. F., & Rodnan, G. P. (1968) · Arthritis & Rheumatism · doi:10.1002/art.1780110502 · Cited by 139
Anticentromere and Anticentriole Antibodies in the Scleroderma Spectrum
Tuffanelli, D. L. (1983) · Archives of Dermatology · doi:10.1001/archderm.119.7.560 · Cited by 135
McCarty, G. A., Rice, J. R., Bembe, M., & Barada, F. A. (1983) · Arthritis & Rheumatism · doi:10.1002/art.1780260101 · Cited by 111
Evolution of primary raynaud's phenomenon (raynaud's disease) to connective tissue disease
Gerbracht, D. D., Steen, V. D., Ziegler, G. C., Medsger, T. A., & Rodnan, G. P. (1985) · Arthritis & Rheumatism · doi:10.1002/art.1780280114 · Cited by 101
Self-citation
Cited by
Walker, U. A., Tyndall, A., Czirják, L., Denton, C., Farge-Bancel, D., Kowal-Bielecka, O., Müller-Ladner, U., Bocelli-Tyndall, C., & Matucci-Cerinic, M. (2007) · Annals of the Rheumatic Diseases · doi:10.1136/ard.2006.062901 · Cited by 929
FERRI, C., VALENTINI, G., COZZI, F., SEBASTIANI, M., MICHELASSI, C., LA MONTAGNA, G., BULLO, A., CAZZATO, M., TIRRI, E., STORINO, F., et al. (2002) · Medicine · doi:10.1097/00005792-200203000-00004 · Cited by 764
Autoantibodies in Systemic Sclerosis
Steen, V. D. (2005) · Seminars in Arthritis and Rheumatism · doi:10.1016/j.semarthrit.2005.03.005 · Cited by 684
Self-citationSevere restrictive lung disease in systemic sclerosis
Steen, V. D., Conte, C., Owens, G. R., & Medsger, T. A. (1994) · Arthritis & Rheumatism · doi:10.1002/art.1780370903 · Cited by 526
Self-citationSteen, V., & Medsger, T. A. (2003) · Arthritis & Rheumatism · doi:10.1002/art.10775 · Cited by 494
Self-citation
Metadata
- Authors
- Steen, V. D., Powell, D. L., & Medsger, T. A.
- Venue
- Arthritis & Rheumatism
- Publisher
- Wiley
- Published
- 1988-02
- Volume
- 31
- Issue
- 2
- Pages
- 196-203
- ISSN
- 0004-3591 (ISSN-L)
- 1529-0131
- OpenAlex
- W2081028616
- Cited by
- 573
- References
- 13
- FWCI
- 11.89
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.